Ganymed Robotics, a Paris, France-based developer of laptop imaginative and prescient software program and robotics applied sciences for orthopedic surgeons, raised extra €15M in Series B extension.
The extension, which introduced the entire spherical quantity to €36M, was led by The Fund of the European Innovation Council, by way of its Accelerator Program, and Cap Horn, who invested €14M. Bpifrance, the French nationwide funding financial institution, prolonged a €1M mortgage to finance market entry work. The preliminary Series B shut of €21M, led by Cathay Health and joined by Crédit Mutuel Innovation, Kurma Partners and BNP Paribas Développement, was introduced in July 2022.
The firm intends to use the funds to finalize improvement of its surgical robotic assistant for knee arthroplasty and put together for industrial launch.
Led by CEO Sophie Cahen, Ganymed Robotics is a medical gadget firm creating robotic help applied sciences for orthopedic surgical procedure. The first software is a robotic surgical assistant for knee arthroplasties, a standard intervention related to excessive dissatisfaction charges of above 20%. The firm intends to progressively deploy its know-how to handle a number of different orthopedics indications.
Ganymed Robotics at present employs 30 folks.